PHARMANUTRA SPA (PHN.MI) Fundamental Analysis & Valuation

BIT:PHN • IT0005274094

Current stock price

74.9 EUR
-0.9 (-1.19%)
Last:

This PHN.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. PHN.MI Profitability Analysis

1.1 Basic Checks

  • PHN had positive earnings in the past year.
  • In the past year PHN had a positive cash flow from operations.
  • In the past 5 years PHN has always been profitable.
  • PHN had a positive operating cash flow in each of the past 5 years.
PHN.MI Yearly Net Income VS EBIT VS OCF VS FCFPHN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

  • The Return On Assets of PHN (20.17%) is better than 100.00% of its industry peers.
  • The Return On Equity of PHN (36.55%) is better than 85.71% of its industry peers.
  • PHN has a Return On Invested Capital of 25.72%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PHN is significantly above the industry average of 11.83%.
  • The 3 year average ROIC (17.21%) for PHN is below the current ROIC(25.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 20.17%
ROE 36.55%
ROIC 25.72%
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
PHN.MI Yearly ROA, ROE, ROICPHN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • PHN has a Profit Margin of 13.39%. This is in the better half of the industry: PHN outperforms 64.29% of its industry peers.
  • PHN's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 21.79%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PHN has remained more or less at the same level.
  • The Gross Margin of PHN (97.13%) is better than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of PHN has remained more or less at the same level.
Industry RankSector Rank
OM 21.79%
PM (TTM) 13.39%
GM 97.13%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
PHN.MI Yearly Profit, Operating, Gross MarginsPHN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PHN.MI Health Analysis

2.1 Basic Checks

  • PHN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for PHN remains at a similar level compared to 1 year ago.
  • PHN has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, PHN has an improved debt to assets ratio.
PHN.MI Yearly Shares OutstandingPHN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
PHN.MI Yearly Total Debt VS Total AssetsPHN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • PHN has an Altman-Z score of 11.98. This indicates that PHN is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.98, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • PHN has a debt to FCF ratio of 2.01. This is a good value and a sign of high solvency as PHN would need 2.01 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 2.01, PHN is doing good in the industry, outperforming 71.43% of the companies in the same industry.
  • PHN has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • PHN has a Debt to Equity ratio (0.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 2.01
Altman-Z 11.98
ROIC/WACC3.28
WACC7.85%
PHN.MI Yearly LT Debt VS Equity VS FCFPHN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.19 indicates that PHN has no problem at all paying its short term obligations.
  • PHN has a Current ratio of 2.19. This is amongst the best in the industry. PHN outperforms 92.86% of its industry peers.
  • A Quick Ratio of 1.86 indicates that PHN should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.86, PHN belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 1.86
PHN.MI Yearly Current Assets VS Current LiabilitesPHN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. PHN.MI Growth Analysis

3.1 Past

  • PHN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.84%, which is quite good.
  • PHN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.63% yearly.
  • Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 14.35% in the last year.
  • The Revenue has been growing by 16.59% on average over the past years. This is quite good.
EPS 1Y (TTM)12.84%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%13.11%
Revenue 1Y (TTM)14.35%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%19.45%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.22% on average over the next years. This is quite good.
  • PHN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.06% yearly.
EPS Next Y6.55%
EPS Next 2Y14.68%
EPS Next 3Y17.22%
EPS Next 5YN/A
Revenue Next Year15.29%
Revenue Next 2Y15.09%
Revenue Next 3Y15.07%
Revenue Next 5Y12.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PHN.MI Yearly Revenue VS EstimatesPHN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M 250M
PHN.MI Yearly EPS VS EstimatesPHN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. PHN.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 29.84, PHN can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of PHN indicates a slightly more expensive valuation: PHN is more expensive than 71.43% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.54, PHN is valued at the same level.
  • The Price/Forward Earnings ratio is 29.94, which means the current valuation is very expensive for PHN.
  • Based on the Price/Forward Earnings ratio, PHN is valued more expensive than 85.71% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, PHN is valued a bit more expensive.
Industry RankSector Rank
PE 29.84
Fwd PE 29.94
PHN.MI Price Earnings VS Forward Price EarningsPHN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PHN is valued a bit more expensive than 78.57% of the companies in the same industry.
  • 85.71% of the companies in the same industry are cheaper than PHN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 69.55
EV/EBITDA 16.91
PHN.MI Per share dataPHN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of PHN may justify a higher PE ratio.
  • PHN's earnings are expected to grow with 17.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.56
PEG (5Y)2.04
EPS Next 2Y14.68%
EPS Next 3Y17.22%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. PHN.MI Dividend Analysis

5.1 Amount

  • PHN has a Yearly Dividend Yield of 1.36%. Purely for dividend investing, there may be better candidates out there.
  • PHN's Dividend Yield is slightly below the industry average, which is at 2.37.
  • Compared to the average S&P500 Dividend Yield of 1.89, PHN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.36%

5.2 History

  • On average, the dividend of PHN grows each year by 11.21%, which is quite nice.
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • PHN pays out 39.70% of its income as dividend. This is a sustainable payout ratio.
  • PHN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP39.7%
EPS Next 2Y14.68%
EPS Next 3Y17.22%
PHN.MI Yearly Income VS Free CF VS DividendPHN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M
PHN.MI Dividend Payout.PHN.MI Dividend Payout, showing the Payout Ratio.PHN.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PHN.MI Fundamentals: All Metrics, Ratios and Statistics

PHARMANUTRA SPA

BIT:PHN (3/24/2026, 11:00:29 AM)

74.9

-0.9 (-1.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)03-13
Earnings (Next)05-11
Inst Owners15.64%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap725.03M
Revenue(TTM)180.41M
Net Income(TTM)24.16M
Analysts82.86
Price Target83.98 (12.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.36%
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP39.7%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.28%
EPS NY rev (3m)0.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.53%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)0.43%
Valuation
Industry RankSector Rank
PE 29.84
Fwd PE 29.94
P/S 4.02
P/FCF 69.55
P/OCF 50.18
P/B 10.97
P/tB 17.38
EV/EBITDA 16.91
EPS(TTM)2.51
EY3.35%
EPS(NY)2.5
Fwd EY3.34%
FCF(TTM)1.08
FCFY1.44%
OCF(TTM)1.49
OCFY1.99%
SpS18.64
BVpS6.83
TBVpS4.31
PEG (NY)4.56
PEG (5Y)2.04
Graham Number19.64
Profitability
Industry RankSector Rank
ROA 20.17%
ROE 36.55%
ROCE 44.34%
ROIC 25.72%
ROICexc 34.17%
ROICexgc 53.82%
OM 21.79%
PM (TTM) 13.39%
GM 97.13%
FCFM 5.78%
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexgc growth 3Y-15.98%
ROICexgc growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score7
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 2.01
Debt/EBITDA 0.37
Cap/Depr 112.59%
Cap/Sales 2.23%
Interest Coverage 250
Cash Conversion 33.69%
Profit Quality 43.15%
Current Ratio 2.19
Quick Ratio 1.86
Altman-Z 11.98
F-Score7
WACC7.85%
ROIC/WACC3.28
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.84%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%13.11%
EPS Next Y6.55%
EPS Next 2Y14.68%
EPS Next 3Y17.22%
EPS Next 5YN/A
Revenue 1Y (TTM)14.35%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%19.45%
Revenue Next Year15.29%
Revenue Next 2Y15.09%
Revenue Next 3Y15.07%
Revenue Next 5Y12.06%
EBIT growth 1Y10.97%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year22.37%
EBIT Next 3Y20.23%
EBIT Next 5Y14.04%
FCF growth 1Y164.53%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y18.84%
OCF growth 3Y0.14%
OCF growth 5Y11.34%

PHARMANUTRA SPA / PHN.MI Fundamental Analysis FAQ

What is the fundamental rating for PHN stock?

ChartMill assigns a fundamental rating of 6 / 10 to PHN.MI.


Can you provide the valuation status for PHARMANUTRA SPA?

ChartMill assigns a valuation rating of 1 / 10 to PHARMANUTRA SPA (PHN.MI). This can be considered as Overvalued.


What is the profitability of PHN stock?

PHARMANUTRA SPA (PHN.MI) has a profitability rating of 8 / 10.


How financially healthy is PHARMANUTRA SPA?

The financial health rating of PHARMANUTRA SPA (PHN.MI) is 8 / 10.


Is the dividend of PHARMANUTRA SPA sustainable?

The dividend rating of PHARMANUTRA SPA (PHN.MI) is 4 / 10 and the dividend payout ratio is 39.7%.